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Abstract
Background This study describes the outcomes of internal bone transport with magnetic nails in five cases of traumatic 
segmental femoral bone defects.
Methods Five patients with open fracture of the femur and diaphyseal bone loss were included between May 2018 and 
August 2020. The mean femoral defect was 8.7 cm (range 5.6–16.0).
Intervention We used plate-assisted bone segment transport (PABST) with PRECICE magnetic nails.
Results All five patients have fully consolidated. The mean consolidation time and index were 7.5 months and 0.8 mo/cm, 
respectively. The mean follow-up was 21.3 months. The main complications were reduced knee ROM, mild varus deform-
ity and plate bending. Post-operative SF-36, Oxford Knee scores and ED-5Q-5L scores were also compiled for four of 
five patients. SF-36 and Oxford Knee scores were reported without pre-injury data for comparison. ED-5Q-5L index and 
VAS were compared UK population norm and were both found to be statistically insignificant (p = 0.071 and p = 0.068, 
respectively).
Conclusion Bone transport with magnetic nails has the capacity to obtain good functional recovery in long bone defects 
despite variable outcome pictures. In response to variable outcome reporting in the literature, we propose a standard report-
ing template for future studies to facilitate more rigorous analyses.
Keywords Bone transport · Bone loss · Femur · Magnetic nail
Introduction
Long bone defects (LBDs) are most commonly caused by 
high-energy trauma, but also occur as a result of tumour 
resection and infection. Management of LBDs relies on the 
principles of distraction osteogenesis pioneered by Ilizarov 
[1]. The Iliazarov technique forms the foundation in mod-
ern reconstructive surgery for limb lengthening and bone 
transport. However, it involves external fixation which is 
associated with pin tract infections, systemic infections, 
soft-tissue tethering and decreased knee range of motion [2, 
3]. Recent developments in intramedullary nail lengthening 
systems, a less invasive approach, reduce the aforementioned 
device-related risks, nonetheless have issues reported such 
as mechanical instability and difficulty to control lengthen-
ing [4, 5].
Existing intramedullary nail lengthening systems adopt a 
variety of actuation techniques. Mechanical actuation (e.g. 
Intramedullary Skeletal Kinetic Distractor and Albizzia) and 
motorised systems (Fitbone) each  have their specific limita-
tions in distraction control and stability [5].
The recent development of magnetically actuated nails 
realised advantages over previous implants and a new degree 
of patient manipulation with an external remote controller 
(ERC). Such procedure with a fully implantable system 
requires careful planning to avoid post-operative changes. 
Konofaos et al. [6] demonstrated an early use of a magnetic 
bone transport device (M-Bone; Phenix) in patients with 
primary bone tumours and showed good bone healing. PRE-
CICE nails (NuVasive) are the latest development and have 
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been reported to achieve accurate and precise limb lengthen-
ing [7–10]. Plate-assisted bone segment transport (PABST) 
is principally used in bone transport [11, 12], but modifica-
tions of this technique  have been described to improve varus 
deformity such as by double-plating [13]. The PRECICE 
nail is controlled using an ERC which, when placed over the 
nail on the skin, causes magnet rotation which in turn acti-
vates a motor that extends or retracts the extendible rod [5].
The treatment technique in LBDs is dictated by the 
degree of bone loss: either bone transport or acute shorten-
ing and re-lengthening, each carrying different risk profiles 
[14]. While smaller defects (of up to 6–7 cm in femur) are 
usually managed by acute shortening, the same treatment in 
larger defects risks soft tissue stacking and neurovascular 
compromise [14]. Nonetheless, it is a technique accompa-
nied by a known risk of long-term muscle power loss [15]. 
However, early bone transport was accompanied by serious 
complications associated with external fixation, and thus, 
there was a push for development of methods to reduce time 
in external fixation. Following recent developments, reports 
have shown a more favourable patient satisfaction rate and 
complication profile for internal lengthening device over 
external device [14, 16].
The direction of lengthening is determined by the pattern 
of bone loss, although some other factors to consider are the 
age of the patient, size of the intramedullary canal and proxi-
mal soft tissue, and the need for deformity correction. Distal 
bone loss mandates the use of retrograde nails for better 
control of the final docking position [13]. On the contrary, 
anterograde nails have the tendency to shift the transport 
fragment anteriorly towards the docking site if not correctly 
fixed initially, resulting in missing the docking point.
After the initial treatment, the bone transport surgery 
is delayed by 6 weeks for any signs of spontaneous bone 
regeneration [17]. Although there is no clear guideline on 
the appropriate length of delay, they are not usually less than 
3–4 weeks and Wright et al. had allowed for 8–10 weeks 
to address associated injuries and any active infection [13].
This article describes a series of uses and outcomes of 
PRECICE magnetic nails in femoral segmental diaphyseal 
bone defects.
Patients and methods
Five patients (4 males and 1 female, age 46.8 ± 18.3 years) 
with open fracture of the femur with BDs were included 
between May 2018 and August 2020. All patients had trau-
matic bone loss (mean size 8.7 ± 3.7 cm). One patient is a 
smoker and one is diabetic. Two patients (Patients 1 and 
2) had previously unsuccessful attempts at bone transport 
by MRS Ex-Fix and pulley system, respectively. Patient 2’s 
pulley system failure was due to patient non-compliance.
The initial treatment usually consisted of bone debride-
ment and temporary ex-fix. This was followed by AxSOS 
plate when patient was stable with no sign of infection and 
fit for surgery. After on average 6 weeks if there was no 
spontaneous union [17] we proceeded with PRECICE nail 
and corticotomy. All the operations were performed with the 
PABST technique and by the same surgeon.
All procedures were performed with the transported 
segment pulled in a retrograde direction. The distraction 
process started on the 8th post-operative day at 1 mm/day 
in 4 steps. Patient 3 moderated the rate to 0.5 mm/day 
temporarily due to plate bending and risk of breaking. He 
required several recharging of the nail and exchanged the 
nail for a shorter one. However, he terminated bone trans-
port by PRECICE nails early due to nail jamming of the 
nail and switched to MRS ex-fix and transport over nail for 
final lengthening and docking. The remaining four patients 
completed bone transport with PRECICE nails.
Three pre-distraction lengths of the PRECICE nail were 
used: 215, 230 and 245 mm. The former two consist of a 
telescoping rod that can achieve 50 mm of lengthening, 
while the last allows for 80 mm of lengthening. AxSOS 
plates were used in all cases to secure the positions of 
proximal and distal fragment during the treatment.
Patients were evaluated for consolidation index, time to 
full weight bearing, time to union, knee range of motion 
(ROM) and complications. Consolidation time was defined 
as the end of distraction to full weight bearing in months. 
Consolidation index was defined as the time from end of 
bone transport to full weight bearing divided by the trans-
ported distance. Time to union was defined as the time from 
injury to union confirmation at the docking site. Union was 
assessed by plain radiograph. Knee ROM was assessed 
in follow-up clinics. After recovery, patients were asked 
to complete patient-reported outcome measures (PROM) 
assessments with SF-36 [18], Oxford Knee Score and 
5Q-5D-5L [19] surveys. Where applicable, the result was 
compared to the national average since no pre-operative 
results were available.
In defect size measurement, we accept an X-ray image 
magnification of ~ 10% and that it is not equal amongst the 
patients. The defect size was taken to be the transported dis-
tance of the segment. We aimed for 1–2 cm shorter leg than 
the contralateral leg to enable and improve knee bending 
and speed up the recovery, and hence ignored limb length 
discrepancy (LLD).
Patients were allowed to start partial weight bearing 
as tolerated during transport, but three cases remained 
non-weight bearing until after transport ended. Full 
weight bearing was initiated when X-ray radiographs in 
two dimensions confirmed strong regenerate by blurring 
the corticotomy lines in either AP or lateral view, unless 
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contraindicated by pain and stiffness. Implants were not 
removed post-recovery.
Results
The patient outcomes are summarised in Table 1. Aver-
age consolidation index was 0.8 mo/cm (range 0.5–1.3). 
All progressed to full weight bearing at an average of 
18.7 months (range 9.1–30.6). Average follow-up was 
21.3 months (range 6.8–33.0), but three patients are still 
being followed up. Patient 3 had nail failure, while two 
others had plate bending. Patients 1 and 2 have signifi-
cantly reduced knee range of movement and are receiving 
physiotherapy. Patient 5 has yet to confirm union on CT 
scan.
Four out of five patients completed the PROM assessment 
only after recovery (Table 2). The results for EQ-5D-5L 
were compared to the UK average. The mean EQ index is 
0.536 compared to the national average [20] of 0.856, and 
the EQ VAS is 51.3 compared to 82.8. The SF-36 and OKS 
results are presented without a baseline comparison.
X-ray radiographs were used to assess progress before, 
during and after bone transport (Figs. 1, 2, 3).
Discussion
Bone transport with magnetic nails is a relatively novel 
technique in the armamentarium for long bone defects. 
Currently, few studies exist in the literature, mainly as case 
series or case reports, which aim to describe the procedure 
and characterise the outcomes of interest. The picture of 
patient experience and procedure outcome remains unclear. 
Consolidation of the outcome picture will strengthen its reli-
ability as a tool for surgeons and identify any possible asso-
ciation such that its shortcomings may be improved.
Firstly, the treatment technique has classically been dic-
tated by the defect size: either bone transport or acute short-
ening and re-lengthening. A defect size of 4–5 cm in the 
tibia and 6–7 cm in the femur are conventionally held as 
the limits for choosing acute shortening, [14] while bone 
Table 1  Summary of patient characteristics and outcome




Time to fwb (mo) Time to union (mo)
1 30/M R femur 5.6 7.3 1.3 30.6 30.6
2 40/F L femur 8.0 6.7 0.8 14.5 12.9
3 29/M R femur 16.0 15.0 0.9 27.5 21.4
4 77/M R femur 6.9 4.6 0.7 11.7 7.3
5 58/M L femur 7.0 3.8 0.5 9.1 NA
Average 46.8 8.7 7.5 0.8 18.7 18.1
Span 5.6–16.0 3.8–15.0 0.5–1.3 9.1–30.6 7.3–30.6
Patient Knee ROM F/U (mo) Complications
1 10–90 33.0 None
2 0–90 25.2 None
3 0–120 26.7 Plate bending, nail failure
4 0–120 15.0 Heterotrophic ossification
5 30–115 6.8 Plate bending, mild varus
Average 8–107 21.3
Span 0–120 6.8–33.0
Table 2  SF36, OKS, EQ-5D-5L survey results. Population norm 
taken from Janssen and Szende (2014) [20]
PROM Mean Median SD Range
SF-36
Physical functioning 25 17.5 20.4 10–55
Social functioning 37.5 75 43.3 0–75
Physical limitation of role 0 0 0.0 0–0
Emotional limitation of role 75 100 50.0 0–100
Mental health 61 62 26.6 36–84
Vitality/energy 37.5 35 33.0 5–75
Pain 38.8 38.8 32.0 0–77.5
Global health 46.3 45 22.5 20–75
Health change 43.8 50 31.5 0–75
OKS (0–48) 20.3 19 9.6 11–32
EQ-5D-5L
EQ index 0.536 0.607 0.324 0.112–0.816
Population norm 0.856
EQ VAS 51.3 55 31.2 10–85
Population norm 82.8
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transport is reserved for larger defects. Whilst we accept 
these criteria, we only acutely shorten if there is no other 
option. Our selection partially overlaps with what would 
have traditionally been managed with shortening. Simi-
larly, Olesen et al. [12] treaded on the same boundary with 
a mean femoral defect of 9.3 cm (range 7–11.5) and a mean 
tibial defect of 8.9 cm (range 4.8–15). Wright et al. [13] 
reported a mean femoral defect size of 10.3 cm (range 7–16). 
Barinaga et al. [11] reported on a traumatic tibial fracture 
of 3.0 cm when PABST was indicated, after previous IM 
nail failure when the initial defect was 4.2 cm. The authors 
acknowledged that acute shortening and distraction would 
have normally been indicated for his defect size. Together, 
this highlights the need to elucidate when bone transport 
with magnetic nails should be employed over acute shorten-
ing, and, if any, a lower limit of defect size. Our study echoes 
the obscurity in the suitability of this technique for smaller 
defect sizes, often overridden by expert opinion or patient 
choice. This is an area that warrants assessment in a future 
study. It is essential to clearly demonstrate the absence of 
major complications and a faster return to function in this 
technique over acute shortening.
Secondly, while bone transport with magnetic nails has 
been used in both femoral and tibial bone losses, the scarcity 
of cases have warranted little differentiation between the two 
in early reports. Konofaos et al. [6] presented a mixed report 
Fig. 1  AP (a, b, c) and lateral 
(d, e, f) radiographs of Patient 
1 showing the defect at the 
start, during the retrograde 
bone transport and at the final 
stage. Patient 1 had a previously 
unsuccessful bone transport 
by MRS Ex-Fix before using 
magnetic lengthening nails
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with femoral and tibial cases, while Barinaga et al. [11] 
exclusively reported on three femoral cases. Olesen et al. 
[12] reported on both, but separated the two in their analysis 
and drew very different outcome pictures. They reported on 
nine patients, of these only five are femoral cases. It appears 
critical to differentiate the two locations for they present 
differently, and thus our study maintained homogeneity with 
only femoral cases.
The causes of bone loss should also be considered, which 
are broadly from trauma, infection or post-tumour resection. 
Olesen et al. [12] reported five femoral defects, of which 
three were from trauma, one from osteosarcoma and one 
from thyroid metastasis. Konofaos et al. [6] reported five 
Fig. 2  AP (a, b, c) and lateral 
(d, e, f) radiographs of Patient 
3 showing the defect at the 
start, during the retrograde 
bone transport and at the final 
stage. This demonstrates plate 
bending, as seen in two of our 
patients
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post-tumour resection while Wright et al. [13] and Bari-
naga et al. [11] reported exclusively traumatic bone loss. 
Any differences have not been clearly detected and stated, 
but it is conceivable that a bone tumour pathology would 
result in longer follow-up due to the additional use of adju-
vants. While defect lengths can be the same, post-traumatic 
or post-infection defects behave differently compared to 
tumour-related defects mainly from the infection perspec-
tive and complications. To illustrate, Olesen et  al. [12] 
reported longer follow-up in their non-traumatic cases (aver-
age 34.5 mo) compared to traumatic cases (average 19 mo). 
Konofaos et  al.’s [6] cases were all on chemotherapy, 
Fig. 3  AP (a, b, c) and lateral 
(d, e, f) radiographs of Patient 
4 showing the defect at the 
start, during the retrograde bone 
transport and at the final stage
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although their reported follow-up did not reflect this. Our 
series (average 21.3 mo) included only traumatic bone loss 
to maintain homogeneity of our sample.
In this study, we assess the outcomes of our interven-
tion to highlight different aspects of its utility, which can 
be broadly categorised into functional recovery, radiologi-
cal evidence, follow-up and complications. There is clearly 
variation in the details that are being reported. We attempt to 
establish essential outcome reporting, in order to accurately 
characterise the effect of this intervention.
Functional outcome
One major aspect in the assessment of functional recovery is 
consolidation index. Our mean index of 0.8 mo/cm closely 
matches to that of 0.9 mo/cm reported by Olesen et al. [12] 
in the femur. However, a direct comparison may be ren-
dered invalid as we adopted different key term definitions. 
Their consolidation index was defined as ‘the time from 
corticotomy to radiographic consolidation… divided by the 
transport distance’ [12]. They also reported a mean tibial 
consolidation index of 1.26 mo/cm [12], which is similar to 
that of 56.9 days/cm reported by Barinaga et al. [11] with the 
Accordion technique, further highlighting the need to sepa-
rate the bones in reporting. However, Barinaga et al. [11] 
did not define their consolidation index, which renders any 
direct comparison obscure. In addition, consolidation indi-
ces were not consistently reported in other studies. Wright 
et al. [13] deliberately did not report on consolidation index 
because it was deemed redundant by their method. Besides 
PABST, they introduced additional interventions such as 
medial plating and immediate physiotherapy and weight-
bearing during transport. Rather than a straight assessment 
of PABST, their study claimed to act as a proof of concept 
for these additional interventions to allow earlier return to 
function, thus negating the need for reporting the consolida-
tion time.
Our definition of consolidation index allowed us to bypass 
the implant’s limitations, by starting at the end of bone dis-
traction rather than the time from corticotomy. The mag-
netic implant is limited by the nail length and device failure. 
While repeated use with the PRECICE nail left in situ is an 
established practice in the literature, recharges are some-
times required to achieve full lengthening. The stroke size 
of nail was insufficient in large bone defects such that one 
of our cases needed three recharges. Wright et al. [13] simi-
larly reported two cycles of lengthening with the same nail 
in three patients. Another limitation is device failure. This 
is commonly caused by failed communication between the 
ERC and the magnet within the nail, which is critical for nail 
lengthening post-operatively. An increased distance between 
the ERC and magnet in obese patients due to greater proxi-
mal soft tissue depth may limit the use of an anterograde 
approach, thus a retrograde approach is preferred. In our 
series, we encountered one case of device failure, which 
was later found to be due to nail jamming as a result of three 
point loading of the nail during the shortening phase. This 
time difference may be subtle in uneventful surgeries, but 
have the capacity to cause significant variations in small 
samples where implant limitations may confound the results. 
It is generally accepted that consolidation index is an impor-
tant aspect of outcome, and any meaningful comparison 
between studies requires a consistent key term definition.
Another key aspect of assessing functional outcome is 
time to full weight-bearing. Our average time to full weight 
bearing is 18.7 mo (range 9.1–30.6), while Olesen et al. 
[12] reported 5 mo (range 4–6). They allowed 10–20 kg 
of weight-bearing during transport, and then as tolerated 
after docking, but recommended waiting until full consoli-
dation of regenerate before full weight-bearing. Our study 
employed similar advice, but the large difference in time to 
weight-bearing may be due to a number of factors. Three 
factors are discussed as follows. Firstly, this can be partially 
attributed to key term definition again: while time to full 
weight-bearing is often taken to be from the injury date to 
full weight-bearing, large variations may arise if PABST 
was not the primary indication but other techniques were tri-
alled and failed first. Barinaga et al. [11] reported a time to 
weight-bearing of POD 156, which was similar to Olesen 
et al.’s. Although not specified, it is a reasonably guess that 
Olesen et al. may have adopted the same approach.
Secondly, patient-specific factors may have contributed to 
the large time difference as three of our cases did not weight-
bear during transport due to slow regenerate. Slow regenera-
tion can be potentially attributed to the diaphyseal location 
of corticotomy [11] or the transport rate being too fast. We 
allowed 0.25 mm 4 times daily. There is a slight variation in 
the transport regimen in the literature. Barinaga et al. [11] 
opted for 0.25 mm 3 times daily which was followed by the 
Accordion technique to compensate for slow regeneration. 
Wright et al. [13] followed 0.33 mm 3 times daily which was 
complemented by double-plating and early physiotherapy 
and full weight-bearing. Olesen et al. [12] adopted a mix of 
0.25–0.33 mm 3–4 times daily, dependent on patient factors 
(e.g. smoker or elderly), and moderated from reviewing bone 
formation during follow-ups. We permitted a similar flex-
ibility in our regimen by allowing Patient 3 to reduce rate to 
0.5 mm/day to avoid plate breaking and then increased the 
rate to 1.6 mm/day for 2 weeks after replacing his nail. How-
ever, the nail continued to jam so we switched to monorail 
ex-fix. Other cases in our series tolerated our standard rate 
and had no changes during the course of bone transport. Our 
transport regimen is very similar to that of Olesen et al.’s, 
therefore the cause of slow regenerate may be attributed to 
elsewhere.
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Finally, delayed virtual follow-up assessments during the 
COVID-19 pandemic in two of our cases may have had a 
minor contribution to a longer time to full weight-bearing.
The last aspect of functional recovery assessment is joint 
ROM, which was assessed in follow-up clinics. Our average 
knee ROM is 8–107 and Olesen et al. [12] reported 0–150. 
Their post-intervention range appears to be greater than the 
normative reference values reported by McKay et al. [21], 
which are 1–136 (males) and 2–137 (females). Wright et al. 
[13] reported two of three cases achieving full knee ROM 
and full weight bearing during the bone transport phase, 
despite still consolidating at the docking site at the time of 
their study. Their intervention may be too different from 
ours in order to make a valid comparison, but they serve 
to illustrate the possibility of a faster functional recovery 
with a more aggressive approach. Konofaos et al. [6] only 
reported a simple subjective grading of lower limb function 
(i.e. ‘Excellent/Good’ with no specified ranges) without joint 
ROM or time to full weight bearing, which was inadequate 
for comparison. In addition, we find that typically only knee 
ROM is reported in the literature, while we think it may be 
worthwhile to also assess hip ROM too in femoral cases.
Besides the aforementioned outcomes, an addition of 
PROMs would provide a valuable aspect of lower limb 
functional recovery. Although PROMs were commonly 
not reported, we attempted to report this post-intervention, 
but we were unable to obtain pre-injury data for intra-study 
comparison and thus used population norms instead. We per-
formed a one-tailed one-sample t-test and our series found 
a statistically insignificant mean EQ-5D index (M = 0.536, 
SD = 0.324) compared to that found in the UK population as 
a whole, t(3) = 1.98, p = 0.071. Similarly, we found no sig-
nificant mean EQ-5D VAS (M = 51.3, SD = 31.2) compared 
to the population norm, t(3) = 2.02, p = 0.068. When inter-
preted together with the OKS and SF-36 outcomes, which 
show largely reduced functions across all health dimensions, 
the resulting clinical picture appears conflicting. Pre-injury 
data and a larger sample size are needed to determine if the 
intervention decreases disease burden.
Radiological outcome
Radiological outcome is sometimes reported as time to 
union, whereby radiological assessment is used. Our mean 
time to union was 18.1mo (range 7.3–30.6), while Olesen 
et al. [12] reported 8.5 mo (range 5–12) in the femur and 
7.5 mo (range 6–9) in the tibia. Barinaga et al. [11] reported 
18 mo (defined as after PRECICE 2 IM nail placement to 
radiographic evidence) for their single tibia case. This large 
variation can be accounted for by time to union definitions, 
frequency of imaging and patient factors.
Follow‑up
Follow-up as an outcome was unexpectedly under-
reported. Our mean follow-up is 21.3 mo (range 6.8–33.0). 
Olesen et al. [12] reported an average follow-up of 25 mo 
(range 18–36) for femoral cases and 10.5 mo (range 4–13) 
for tibial cases, although this outcome measure was not 
consistently reported by other authors. Konofaos et al. [6] 
reported an average follow-up of 11 mo (range 6–17), but 
proposed that more data are required to conclude the tech-
nique’s long-term structural integrity. In their case, it may 
be that follow-up had not been carried out over a sufficient 
time period. We believe that follow-up is needed to deter-
mine the long-term reliability of this technique.
Complications
General complications associated with bone transport are 
heterotrophic ossifications, soft tissue contracture, super-
ficial infection, delayed union of docking sites, reduced 
joint movement, and malalignment resulting in varus 
deformities. In our series, patients reported pain from 
heterotrophic ossification, slow regenerate, reduced knee 
ROM, mild varus deformity, two cases of plate bending, 
and one case of nail failure. We had one case of minor 
varus deformity which was left uncorrected. Significant 
malalignment that develops post-operatively could be cor-
rected with a secondary trauma nail or by relocking the 
plate to the bone [12]. Our reported set of complications 
are very similar to those reported in the literature. Kono-
faos et al.’s [6] reporting of complications was limited to 
either infection or hardware failure. Barinaga et al. [11] 
reported slow regenerate and non-union while Wright et al. 
[13] reported knee stiffness, tibial fracture on manipula-
tion. Olesen et al. [12] reported heterotrophic ossification, 
contracture, delayed union, superficial infection and mild 
varus deformity.
As illustrated, significant inter-study differences exist 
in the current literature for the intervention bone transport 
with magnetic nails in LBDs, rendering most comparisons 
invalid. We have demonstrated that it is difficult to extract 
useful conclusions about the characteristics and application 
of this technique. However, the current studies provide some 
scope for such technique as a management option for large 
femoral BDs in different clinical scenarios, whilst identify-
ing potential complications.
Limitations
The strengths of our study are the homogeneity of patients 
and fracture type, PROMs and consistency of the surgical 
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technique, while our main shortcomings are small sample 
size, retrospective design and lack of baseline assessment in 
PROMs. Most case reports provided a detailed description 
of the surgical technique, pre- and post-operative care. We 
did not provide a description here because we have taken a 
standard approach.
Future directions
A review of the current literature along with our study elu-
cidated limitations in our current understanding of the tech-
nique bone transport with magnetic nails. A comprehensive 
reporting of outcomes is essential for valid comparisons 
between case series, providing key term definitions. Our 
study reported on exclusively traumatic femoral defects. 
Maintaining defect homogeneity by location and pathology 
in participant selection can reveal a different outcome pic-
ture and may uncover valuable insights into the suitability 
of this technique in various clinical scenarios. Finally, a 
more rigorous establishment of the technique’s indication 
with regards to defect size is needed, and particularly its 
indications over acute shortening and re-lengthening for 
smaller defect sizes. We propose a standard reporting tem-
plate (Table 3) for future bone transport studies to enable 
easier meta-analysis in the future.
Conclusion
In conclusion, bone transport with magnetic nails for long 
bone defects remains a relatively unchartered territory, prin-
cipally backed by expert opinion and anecdotal evidence. We 
have contributed one perspective of its use in traumatic fem-
oral defects with a small sample of five, and have attempted 
to identify key outcome measures that would assist in build-
ing a meaningful picture of patient experience and procedure 
outcome.
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Table 3  A proposed standard reporting template for future bone transport studies
*Consolidation time/index, time to full-weight bearing, time to union and follow-up are all time-dependent outcomes, hence a clear definition 
must be provided
Part Item # Checklist item
A—Patient characteristics 1 The report contains basic details of age, sex, co-morbidities and other treatments/features which may influ-
ence follow-up
2 The report contains information on defect pathology (e.g. traumatic, infection, tumour), defect size (primary 
and/or secondary if other techniques had been trialled first, distraction distance if incomplete transport and 
length difference), defect location (laterality and bone(s) involved)
B—Method 1 The report provides adequate description of technique employed, surgical modality, implants/devices used 
and whether carried out by same surgeon. If the key technique was adapted or if other techniques deliv-
ered, then describe why, when and how
2 The report outlines the clinical management of patient (e.g. pre-operative and post-operative care)
3 Any significant time delays that may influence the measured time-dependent outcome
C—Functional outcome 1 Consolidation time/index*, time to full weight-bearing*, adjacent joint ROMs, PROMs (e.g. EQ-5D-5L, 
SF-36) for both pre- and post-intervention
D—Radiological outcome 1 Time to union*
E—Other characteristics 1 Follow-up*, complications, additional notes
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